ERGOCALCIFEROL

ERGOCALCIFEROL was reported 29732 times

ERGOCALCIFEROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 110 0.6145
1 GRIP STRENGTH 132 0.5764
2 VAGINAL FLATULENCE 137 0.4521
3 CENTRAL NERVOUS SYSTEM MASS 40 0.4211
4 SPIROMETRY ABNORMAL 234 0.3913
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 783 0.3909
6 LUPUS VULGARIS 492 0.3905
7 PULMONARY VASCULITIS 204 0.3792
8 WALL MOTION SCORE INDEX ABNORMAL 40 0.3636
9 MITE ALLERGY 232 0.3542
10 C-REACTIVE PROTEIN 325 0.3506
11 AIRWAY REMODELLING 43 0.3468
12 NEUROLOGIC NEGLECT SYNDROME 192 0.3453
13 SWOLLEN JOINT COUNT 85 0.3400
14 MYCOTIC ALLERGY 288 0.3368
15 PRESBYACUSIS 101 0.3279
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 180 0.3209
17 BRONCHIAL NEOPLASM 41 0.3015
18 TOTAL LUNG CAPACITY ABNORMAL 117 0.3008
19 RHEUMATIC FEVER 1291 0.2893
20 X-RAY ABNORMAL 509 0.2844
21 FACET JOINT SYNDROME 924 0.2835
22 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 570 0.2748
23 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 180 0.2695
24 EJECTION FRACTION 155 0.2668
25 SENSITISATION 201 0.2648
26 DISLOCATION OF VERTEBRA 580 0.2541
27 SWOLLEN JOINT COUNT INCREASED 792 0.2481
28 DUST ALLERGY 234 0.2385
29 RHEUMATOID FACTOR POSITIVE 1337 0.2312
30 HYPOCHOLESTEROLAEMIA 81 0.2295
31 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1631 0.2274
32 CAROTID ARTERY THROMBOSIS 191 0.2250
33 HEPATIC ENZYME 33 0.2215
34 CAPILLARITIS 61 0.2210
35 PERIPHERAL VENOUS DISEASE 898 0.2197
36 DUODENAL ULCER PERFORATION 1614 0.2168
37 C-REACTIVE PROTEIN ABNORMAL 1292 0.2012
38 VASCULAR MALFORMATION 41 0.1952
39 RETINITIS 335 0.1938
40 ATOPY 50 0.1799
41 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 131 0.1787
42 PARANASAL CYST 42 0.1728
43 MUSCLE INJURY 1392 0.1678
44 CONJUNCTIVITIS ALLERGIC 244 0.1646
45 PLEURAL THICKENING 104 0.1520
46 OVERLAP SYNDROME 106 0.1514
47 FOLLICULITIS 1577 0.1502
48 HELICOBACTER INFECTION 1541 0.1498
49 PORPHYRIA ACUTE 209 0.1456
50 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 936 0.1440
51 ADJUSTMENT DISORDER 187 0.1438
52 PEMPHIGUS 1773 0.1417
53 NASAL OEDEMA 247 0.1366
54 BREAST CANCER STAGE III 870 0.1342
55 NEURITIS 204 0.1320
56 BRONCHIAL HAEMORRHAGE 41 0.1314
57 POLYCYSTIC OVARIES 203 0.1308
58 GRANULOMA SKIN 106 0.1291
59 BONE EROSION 442 0.1249
60 OBSTRUCTIVE SLEEP APNOEA SYNDROME 178 0.1220
61 HAND DEFORMITY 1573 0.1198
62 SYNOVITIS 2123 0.1176
63 ONYCHOMADESIS 492 0.1171
64 MULTIPLE DRUG THERAPY 88 0.1167
65 NASAL TURBINATE HYPERTROPHY 43 0.1141
66 LIP DRY 1028 0.1131
67 ENDOMETRIAL ABLATION 40 0.1120
68 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 220 0.1078
69 PERICARDITIS 1766 0.1050
70 PLEURAL FIBROSIS 104 0.1021
71 RESPIRATORY SYMPTOM 288 0.1012
72 APPENDICOLITH 39 0.1008
73 DRUG TOLERANCE DECREASED 278 0.0989
74 JOINT RANGE OF MOTION DECREASED 1240 0.0924
75 BLOOD MAGNESIUM INCREASED 83 0.0920
76 BURSITIS 1110 0.0914
77 BLEPHAROSPASM 576 0.0914
78 FEMALE GENITAL TRACT FISTULA 151 0.0884
79 BLOOD PARATHYROID HORMONE DECREASED 125 0.0843
80 AUTOIMMUNE DISORDER 796 0.0816
81 WOUND INFECTION 886 0.0808
82 HYPERCHOLESTEROLAEMIA 779 0.0806
83 BRONCHIAL WALL THICKENING 57 0.0793
84 NORMOCHROMIC NORMOCYTIC ANAEMIA 238 0.0791
85 BONE CYST 74 0.0789
86 LIVE BIRTH 658 0.0786
87 GRIP STRENGTH DECREASED 690 0.0783
88 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 180 0.0781
89 SPUTUM PURULENT 50 0.0760
90 PERSONALITY DISORDER 196 0.0748
91 JOINT ANKYLOSIS 42 0.0739
92 MYOGLOBIN BLOOD INCREASED 112 0.0732
93 FIBROMYALGIA 1773 0.0729
94 GLOSSODYNIA 1596 0.0712
95 ONYCHOMYCOSIS 311 0.0708
96 URINE LEUKOCYTE ESTERASE POSITIVE 48 0.0686
97 INFUSION SITE REACTION 205 0.0686
98 IRRITABLE BOWEL SYNDROME 1470 0.0685
99 DRUG SPECIFIC ANTIBODY 92 0.0672
100 CHRONIC SINUSITIS 244 0.0649
101 EJECTION FRACTION ABNORMAL 78 0.0636
102 CREATININE RENAL CLEARANCE INCREASED 46 0.0615
103 WOUND 1717 0.0614
104 BREAST CONSERVING SURGERY 31 0.0605
105 OBESITY 935 0.0586
106 NEPHRECTOMY 87 0.0585
107 RADICULOPATHY 152 0.0576
108 OBSTRUCTIVE AIRWAYS DISORDER 631 0.0567
109 BLOOD IMMUNOGLOBULIN M INCREASED 34 0.0559
110 FINGER DEFORMITY 271 0.0559
111 RHONCHI 77 0.0557
112 PULMONARY FIBROSIS 1056 0.0550
113 EOSINOPHILIC MYOCARDITIS 40 0.0548
114 LIVER INJURY 1344 0.0547
115 PUSTULAR PSORIASIS 188 0.0547
116 CARDIAC SEPTAL DEFECT 39 0.0542
117 CONTRAINDICATED PRODUCT ADMINISTERED 1633 0.0539
118 BLOOD IMMUNOGLOBULIN A DECREASED 35 0.0538
119 SERONEGATIVE ARTHRITIS 61 0.0532
120 EXOSTOSIS 480 0.0525
121 PROCTITIS 146 0.0521
122 RED BLOOD CELL SEDIMENTATION RATE INCREASED 576 0.0520
123 RHINITIS ALLERGIC 229 0.0514
124 SYSTEMIC LUPUS ERYTHEMATOSUS 1791 0.0504
125 FORCED EXPIRATORY VOLUME DECREASED 142 0.0501
126 FULL BLOOD COUNT ABNORMAL 530 0.0501
127 MASTOIDITIS 48 0.0489
128 WHEEZING 2853 0.0481
129 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 809 0.0476
130 PSORIATIC ARTHROPATHY 1908 0.0470
131 LOWER RESPIRATORY TRACT INFECTION 2135 0.0469
132 TYPE 2 DIABETES MELLITUS 1563 0.0464
133 RHEUMATOID NODULE 127 0.0461
134 MUSCLE SPASTICITY 566 0.0460
135 MATERNAL EXPOSURE TIMING UNSPECIFIED 173 0.0460
136 PANNICULITIS 110 0.0454
137 IMPAIRED HEALING 1486 0.0452
138 SCIATICA 708 0.0444
139 LOWER LIMB FRACTURE 848 0.0441
140 ARTERIOSCLEROSIS CORONARY ARTERY 292 0.0440
141 NIGHT SWEATS 1410 0.0437
142 ULCER HAEMORRHAGE 293 0.0433
143 BREAST CANCER STAGE II 358 0.0430
144 NAIL DISORDER 376 0.0429
145 BACK INJURY 464 0.0426
146 MICROANGIOPATHY 40 0.0426
147 CENTRAL OBESITY 31 0.0419
148 SKIN NEOPLASM EXCISION 32 0.0409
149 BREATH SOUNDS ABNORMAL 197 0.0399
150 ENTHESOPATHY 62 0.0396
151 WALKING AID USER 261 0.0395
152 GAIT INABILITY 1301 0.0389
153 MACULAR DEGENERATION 462 0.0386
154 NEUROLOGICAL SYMPTOM 215 0.0376
155 RASH VESICULAR 181 0.0374
156 BRAIN NATRIURETIC PEPTIDE INCREASED 115 0.0373
157 PULMONARY ALVEOLAR HAEMORRHAGE 208 0.0370
158 PLANTAR FASCIITIS 124 0.0369
159 OSTEOARTHRITIS 1525 0.0359
160 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 38 0.0358
161 SECONDARY IMMUNODEFICIENCY 43 0.0354
162 DEAFNESS NEUROSENSORY 115 0.0349
163 THERAPEUTIC PRODUCT EFFECT DECREASED 1563 0.0349
164 EYE INJURY 106 0.0349
165 OEDEMA 1892 0.0349
166 ARTHROPATHY 1932 0.0347
167 PRESCRIBED OVERDOSE 658 0.0340
168 OSTEOSCLEROSIS 53 0.0336
169 C-REACTIVE PROTEIN INCREASED 1219 0.0335
170 BLOOD CHOLESTEROL INCREASED 1535 0.0329
171 FOOT DEFORMITY 358 0.0323
172 PRODUCT LABEL CONFUSION 183 0.0314
173 BLOOD IMMUNOGLOBULIN G INCREASED 38 0.0312
174 LUPUS-LIKE SYNDROME 281 0.0310
175 EAR PAIN 602 0.0309
176 INFUSION RELATED REACTION 2047 0.0309
177 GANGRENE 186 0.0308
178 COLITIS MICROSCOPIC 145 0.0306
179 ARTERIOSCLEROSIS 277 0.0294
180 HEPATIC ENZYME INCREASED 2005 0.0294
181 ALANINE AMINOTRANSFERASE ABNORMAL 62 0.0294
182 CONGENITAL ANOMALY 227 0.0293
183 BLISTER 1636 0.0291
184 SENSORY LOSS 232 0.0288
185 HIP ARTHROPLASTY 436 0.0284
186 NODULE 365 0.0279
187 EPIGASTRIC DISCOMFORT 108 0.0276
188 LUNG DISORDER 1355 0.0276
189 TASTE DISORDER 554 0.0273
190 BRONCHIAL DISORDER 42 0.0270
191 DRUG INTOLERANCE 2550 0.0264
192 STOMATITIS 1596 0.0263
193 PRESCRIBED UNDERDOSE 522 0.0261
194 LYMPHOCYTE PERCENTAGE DECREASED 35 0.0260
195 COELIAC DISEASE 254 0.0259
196 BLOOD IMMUNOGLOBULIN E INCREASED 62 0.0256
197 ARTERIAL OCCLUSIVE DISEASE 200 0.0254
198 ASTHMA 2874 0.0254
199 RHEUMATOID ARTHRITIS 2871 0.0253
200 ENDOMETRIOSIS 120 0.0251
201 NEOPLASM SKIN 39 0.0251
202 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1205 0.0251
203 HEPATIC CIRRHOSIS 467 0.0248
204 MUSCULOSKELETAL PAIN 1277 0.0244
205 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1733 0.0243
206 BLOOD TEST ABNORMAL 339 0.0241
207 CALCIPHYLAXIS 44 0.0240
208 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 410 0.0239
209 HEMIPLEGIA 198 0.0238
210 BRONCHIAL OBSTRUCTION 33 0.0235
211 AFFECT LABILITY 226 0.0235
212 DISCOMFORT 1430 0.0234
213 JOINT DESTRUCTION 36 0.0231
214 NASAL POLYPS 114 0.0231
215 MOBILITY DECREASED 1658 0.0231
216 JOINT SWELLING 2768 0.0229
217 JOINT DISLOCATION 240 0.0227
218 TREATMENT FAILURE 1851 0.0223
219 SLEEP DISORDER 1576 0.0223
220 RESPIRATORY DISORDER 668 0.0223
221 SACROILIITIS 42 0.0222
222 HEPATIC ENZYME ABNORMAL 111 0.0222
223 RHEUMATIC DISORDER 43 0.0222
224 RECALLED PRODUCT 38 0.0219
225 RESPIRATORY TRACT INFECTION 571 0.0219
226 INFLAMMATION 1125 0.0218
227 SKIN NECROSIS 112 0.0216
228 VASCULITIS 251 0.0215
229 MYOSITIS 193 0.0215
230 NORMAL NEWBORN 116 0.0213
231 BODY TEMPERATURE INCREASED 432 0.0212
232 SEDATION COMPLICATION 54 0.0211
233 LIVER FUNCTION TEST INCREASED 452 0.0210
234 CARPAL TUNNEL SYNDROME 294 0.0210
235 MOTOR DYSFUNCTION 212 0.0208
236 NASAL OBSTRUCTION 39 0.0208
237 HYPERPARATHYROIDISM SECONDARY 52 0.0207
238 LIVER DISORDER 913 0.0206
239 HYPERPHOSPHATAEMIA 44 0.0204
240 GASTROINTESTINAL DISORDER 1827 0.0204
241 KNEE ARTHROPLASTY 426 0.0202
242 FREQUENT BOWEL MOVEMENTS 546 0.0202
243 SINUS CONGESTION 273 0.0202
244 INJURY 1418 0.0202
245 BODY TEMPERATURE DECREASED 198 0.0201
246 URINE ABNORMALITY 91 0.0200
247 MUSCULOSKELETAL STIFFNESS 1747 0.0199
248 HYPERCALCAEMIA 245 0.0198
249 BLOOD PRESSURE SYSTOLIC ABNORMAL 49 0.0198
250 EPILEPSY 601 0.0196
251 OSTEOLYSIS 40 0.0196
252 SWELLING 1826 0.0195
253 ILL-DEFINED DISORDER 1179 0.0194
254 GENERAL SYMPTOM 145 0.0193
255 DYSLIPIDAEMIA 98 0.0193
256 BONE LESION 69 0.0191
257 IRON DEFICIENCY 86 0.0191
258 BLOOD PRESSURE DIASTOLIC DECREASED 141 0.0191
259 SINUSITIS 1957 0.0191
260 ROAD TRAFFIC ACCIDENT 791 0.0189
261 RESPIRATORY TRACT CONGESTION 298 0.0187
262 SLEEP APNOEA SYNDROME 354 0.0185
263 BLOOD PRESSURE DIASTOLIC ABNORMAL 46 0.0181
264 WHITE BLOOD CELLS URINE POSITIVE 34 0.0181
265 DELIRIUM 626 0.0180
266 MATERNAL EXPOSURE DURING PREGNANCY 1605 0.0180
267 INTENTIONAL PRODUCT USE ISSUE 1577 0.0180
268 JUVENILE IDIOPATHIC ARTHRITIS 44 0.0180
269 DRY MOUTH 1441 0.0177
270 EXERCISE TOLERANCE DECREASED 100 0.0174
271 OTITIS MEDIA 57 0.0172
272 EOSINOPHIL COUNT DECREASED 41 0.0172
273 BLOOD PHOSPHORUS INCREASED 47 0.0172
274 THERAPY NON-RESPONDER 770 0.0171
275 VITAMIN D DEFICIENCY 167 0.0171
276 LUNG OPACITY 45 0.0171
277 OSTEOPENIA 259 0.0170
278 NEPHROGENIC ANAEMIA 79 0.0170
279 RED CELL DISTRIBUTION WIDTH INCREASED 70 0.0168
280 PREGNANCY 336 0.0168
281 CREATININE RENAL CLEARANCE DECREASED 67 0.0167
282 DRUG-INDUCED LIVER INJURY 524 0.0167
283 SKIN HAEMORRHAGE 247 0.0166
284 VITAMIN B12 DECREASED 48 0.0166
285 DRUG TOLERANCE 84 0.0166
286 CONTUSION 1583 0.0164
287 PERIPHERAL SWELLING 2467 0.0160
288 SINUS DISORDER 316 0.0159
289 ADVERSE REACTION 211 0.0159
290 EOSINOPHIL COUNT INCREASED 132 0.0158
291 GASTROOESOPHAGEAL REFLUX DISEASE 1269 0.0157
292 BRONCHIECTASIS 106 0.0157
293 PRODUCTIVE COUGH 751 0.0157
294 LYMPHADENITIS 38 0.0157
295 GRANULOMA 54 0.0156
296 SPINAL STENOSIS 63 0.0152
297 GENERAL PHYSICAL HEALTH DETERIORATION 1765 0.0152
298 VAGINAL DISCHARGE 154 0.0152
299 HEPATITIS 389 0.0152
300 COORDINATION ABNORMAL 212 0.0152
301 OSTEOPOROSIS 623 0.0151
302 HYPOTHYROIDISM 476 0.0149
303 SENSATION OF FOREIGN BODY 125 0.0148
304 WEIGHT FLUCTUATION 155 0.0148
305 ORAL CANDIDIASIS 193 0.0146
306 PULMONARY FUNCTION TEST DECREASED 63 0.0144
307 RHINITIS 116 0.0144
308 BLOOD PRESSURE DIASTOLIC INCREASED 66 0.0143
309 BLOOD PRESSURE SYSTOLIC INCREASED 278 0.0142
310 DISABILITY 280 0.0141
311 HEMIPARESIS 239 0.0141
312 URINE ANALYSIS ABNORMAL 42 0.0140
313 BACK DISORDER 228 0.0140
314 SPONDYLITIS 50 0.0137
315 EOSINOPHILIA 237 0.0135
316 TENOSYNOVITIS 37 0.0134
317 NASOPHARYNGITIS 2469 0.0134
318 RENAL FUNCTION TEST ABNORMAL 62 0.0133
319 ARTHRITIS 1045 0.0133
320 OBSTRUCTION 53 0.0133
321 MIGRAINE 1260 0.0132
322 CUSHINGOID 42 0.0131
323 VENTRICULAR HYPOKINESIA 42 0.0131
324 CONFUSIONAL STATE 2107 0.0130
325 PARAESTHESIA ORAL 188 0.0130
326 EOSINOPHILIC PNEUMONIA 41 0.0130
327 EAR INFECTION 346 0.0130
328 BLOOD PRESSURE INADEQUATELY CONTROLLED 78 0.0130
329 JOINT STIFFNESS 340 0.0129
330 DYSPEPSIA 1252 0.0127
331 HYPERTENSION 2691 0.0127
332 INFECTION 1820 0.0126
333 ABDOMINAL DISCOMFORT 2096 0.0125
334 URTICARIA 2090 0.0125
335 INCREASED UPPER AIRWAY SECRETION 64 0.0125
336 HEPATIC FIBROSIS 42 0.0122
337 DRUG LEVEL BELOW THERAPEUTIC 67 0.0121
338 SNEEZING 272 0.0121
339 BLOOD PRESSURE FLUCTUATION 291 0.0121
340 MULTIPLE ALLERGIES 95 0.0121
341 SECRETION DISCHARGE 150 0.0120
342 EATING DISORDER 253 0.0119
343 AORTIC STENOSIS 41 0.0118
344 AMNESIA 753 0.0116
345 EXPOSURE DURING PREGNANCY 719 0.0116
346 LARGE INTESTINE POLYP 80 0.0115
347 HYPOPHOSPHATAEMIA 85 0.0115
348 THROAT CLEARING 43 0.0115
349 RECTAL HAEMORRHAGE 492 0.0114
350 MUSCULAR WEAKNESS 1299 0.0114
351 PULMONARY MASS 170 0.0114
352 HYPOAESTHESIA 1705 0.0114
353 HYPERSENSITIVITY 2102 0.0113
354 NEPHROPATHY 105 0.0112
355 SPUTUM DISCOLOURED 106 0.0112
356 BLOOD CREATININE DECREASED 35 0.0112
357 NECK PAIN 624 0.0112
358 GLAUCOMA 215 0.0112
359 HEPATIC NECROSIS 42 0.0111
360 COLITIS ULCERATIVE 497 0.0111
361 PRE-EXISTING CONDITION IMPROVED 69 0.0110
362 POLYMYALGIA RHEUMATICA 35 0.0110
363 ULCER 175 0.0110
364 CONDITION AGGRAVATED 3340 0.0110
365 JOINT LOCK 31 0.0109
366 ABDOMINAL PAIN UPPER 2223 0.0108
367 FIBROSIS 33 0.0107
368 ALOPECIA 2105 0.0107
369 CYSTITIS 340 0.0107
370 HEART RATE ABNORMAL 59 0.0106
371 UPPER-AIRWAY COUGH SYNDROME 87 0.0105
372 SKIN INJURY 35 0.0105
373 BLOOD MAGNESIUM DECREASED 91 0.0105
374 CHEST PAIN 1948 0.0105
375 ANAL FISSURE 56 0.0104
376 CYST 127 0.0102
377 VITAMIN D DECREASED 87 0.0102
378 FOREIGN BODY IN THROAT 32 0.0101
379 POOR VENOUS ACCESS 105 0.0101
380 LYMPHOCYTE COUNT DECREASED 179 0.0101
381 SPINAL FUSION SURGERY 41 0.0101
382 VAGINAL INFECTION 47 0.0100
383 BLOOD POTASSIUM INCREASED 162 0.0100
384 RENAL CYST 79 0.0099
385 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 54 0.0099
386 PNEUMONIA 3164 0.0098
387 DRUG SPECIFIC ANTIBODY PRESENT 63 0.0097
388 VITAMIN B12 DEFICIENCY 39 0.0096
389 WEIGHT INCREASED 2152 0.0096
390 RHINORRHOEA 611 0.0094
391 END STAGE RENAL DISEASE 172 0.0094
392 SKIN ATROPHY 54 0.0094
393 BLOOD URIC ACID INCREASED 54 0.0093
394 JOINT EFFUSION 64 0.0093
395 PARANASAL SINUS DISCOMFORT 35 0.0092
396 HAEMOPTYSIS 257 0.0092
397 ASPHYXIA 75 0.0092
398 ANKYLOSING SPONDYLITIS 121 0.0092
399 BLOOD CALCIUM DECREASED 103 0.0092
400 PNEUMONIA ASPIRATION 228 0.0091
401 SKIN REACTION 128 0.0091
402 DYSPNOEA EXERTIONAL 342 0.0091
403 HEART RATE DECREASED 316 0.0090
404 HYPERTRANSAMINASAEMIA 62 0.0089
405 PARAESTHESIA 1392 0.0088
406 APHTHOUS ULCER 68 0.0088
407 HYPOXIA 308 0.0087
408 BASAL CELL CARCINOMA 134 0.0086
409 MEMORY IMPAIRMENT 1174 0.0085
410 LUMBAR VERTEBRAL FRACTURE 39 0.0085
411 PRODUCT USE ISSUE 1597 0.0085
412 SNORING 32 0.0085
413 PNEUMOTHORAX 134 0.0084
414 DIVERTICULITIS 233 0.0084
415 POLYARTHRITIS 44 0.0083
416 HEPATIC STEATOSIS 155 0.0083
417 ATTENTION DEFICIT HYPERACTIVITY DISORDER 35 0.0083
418 BONE DENSITY ABNORMAL 31 0.0083
419 ARTHRALGIA 3441 0.0083
420 CATARACT OPERATION 49 0.0082
421 BOWEL MOVEMENT IRREGULARITY 63 0.0082
422 SUSPECTED OFF LABEL USE 37 0.0082
423 APHASIA 247 0.0082
424 BLOOD THYROID STIMULATING HORMONE DECREASED 37 0.0081
425 OEDEMA PERIPHERAL 987 0.0081
426 GASTROINTESTINAL PAIN 89 0.0081
427 BRONCHITIS 598 0.0081
428 MUSCLE SPASMS 1471 0.0080
429 OVERWEIGHT 43 0.0080
430 FAECES SOFT 58 0.0080
431 ABDOMINAL PAIN 1839 0.0079
432 BLOOD ALBUMIN DECREASED 62 0.0078
433 FEELING HOT 471 0.0077
434 DRUG ERUPTION 136 0.0077
435 LIMB DISCOMFORT 236 0.0076
436 PROTEIN URINE PRESENT 38 0.0076
437 INSOMNIA 2027 0.0076
438 VOMITING 3574 0.0076
439 THYROID DISORDER 117 0.0076
440 ARTHROPOD BITE 56 0.0075
441 BLOOD CALCIUM INCREASED 66 0.0075
442 PAIN IN EXTREMITY 2211 0.0075
443 BLOOD THYROID STIMULATING HORMONE INCREASED 69 0.0075
444 DYSPNOEA 4230 0.0075
445 THERAPEUTIC RESPONSE DECREASED 451 0.0074
446 CATARACT 440 0.0074
447 SKIN LESION 202 0.0074
448 ASTHENIA 2765 0.0073
449 IMMUNODEFICIENCY 109 0.0073
450 ABSCESS LIMB 31 0.0073
451 CHEST DISCOMFORT 744 0.0073
452 ATELECTASIS 70 0.0072
453 ADVERSE EVENT 667 0.0072
454 PERONEAL NERVE PALSY 41 0.0072
455 MEDICATION ERROR 397 0.0071
456 PAIN 4365 0.0071
457 DECREASED APPETITE 1648 0.0071
458 ANGINA PECTORIS 203 0.0071
459 TOOTH ABSCESS 72 0.0071
460 RENAL DISORDER 329 0.0071
461 SKIN WARM 41 0.0070
462 DEPRESSION 1602 0.0070
463 CHRONIC KIDNEY DISEASE 534 0.0070
464 HYPOCALCAEMIA 133 0.0070
465 PYREXIA 2431 0.0070
466 ABDOMINAL DISTENSION 729 0.0070
467 DYSARTHRIA 262 0.0070
468 APPENDICITIS 65 0.0070
469 LABORATORY TEST ABNORMAL 205 0.0069
470 APPETITE DISORDER 46 0.0069
471 UPPER RESPIRATORY TRACT INFECTION 320 0.0069
472 INTERVERTEBRAL DISC DEGENERATION 64 0.0069
473 ANXIETY 1968 0.0069
474 WHITE BLOOD CELL COUNT INCREASED 265 0.0069
475 FLUID RETENTION 350 0.0069
476 MUCOUS STOOLS 34 0.0069
477 PROCEDURAL PAIN 190 0.0068
478 ABDOMINAL TENDERNESS 34 0.0068
479 COLITIS 259 0.0068
480 HERNIA 132 0.0068
481 SKIN ULCER 176 0.0068
482 RALES 39 0.0067
483 RASH 2927 0.0067
484 ABNORMAL FAECES 55 0.0067
485 BLOOD CHOLESTEROL ABNORMAL 31 0.0067
486 PATHOLOGICAL FRACTURE 34 0.0067
487 INJECTION SITE REACTION 458 0.0066
488 HEPATIC ENCEPHALOPATHY 62 0.0066
489 DEFORMITY 62 0.0066
490 NASAL CONGESTION 389 0.0066
491 AFFECTIVE DISORDER 52 0.0066
492 TROPONIN INCREASED 50 0.0066
493 MYASTHENIA GRAVIS 53 0.0066
494 MALAISE 2873 0.0065
495 BLOOD PRESSURE INCREASED 989 0.0065
496 HAEMATOCRIT DECREASED 128 0.0064
497 DIABETES MELLITUS INADEQUATE CONTROL 114 0.0064
498 HAEMATOCHEZIA 354 0.0064
499 RASH PRURITIC 347 0.0064
500 COUGH 1791 0.0064
501 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 32 0.0063
502 RESPIRATORY RATE INCREASED 56 0.0063
503 GAIT DISTURBANCE 1191 0.0062
504 PRODUCT USE IN UNAPPROVED INDICATION 1540 0.0062
505 ANKLE FRACTURE 96 0.0062
506 BLOOD COUNT ABNORMAL 94 0.0062
507 DIVERTICULUM 44 0.0062
508 PRODUCT ADMINISTRATION INTERRUPTED 48 0.0061
509 INFUSION SITE EXTRAVASATION 38 0.0061
510 HEADACHE 3802 0.0061
511 NICOTINE DEPENDENCE 47 0.0060
512 BLOOD CREATININE INCREASED 394 0.0060
513 FOOT FRACTURE 113 0.0060
514 IRON DEFICIENCY ANAEMIA 55 0.0060
515 LOCALISED INFECTION 144 0.0059
516 BURNING SENSATION 417 0.0059
517 IMPAIRED WORK ABILITY 127 0.0059
518 SPINAL OSTEOARTHRITIS 52 0.0059
519 PSORIASIS 773 0.0059
520 ROTATOR CUFF SYNDROME 76 0.0059
521 CLOSTRIDIUM DIFFICILE INFECTION 129 0.0059
522 PLATELET COUNT INCREASED 76 0.0058
523 WEIGHT DECREASED 1613 0.0058
524 SINUS TACHYCARDIA 82 0.0058
525 BLADDER DISORDER 57 0.0057
526 FATIGUE 4457 0.0057
527 PRURITUS 2181 0.0057
528 ADVERSE DRUG REACTION 507 0.0056
529 BEDRIDDEN 74 0.0056
530 ORTHOSTATIC HYPOTENSION 98 0.0056
531 PANCREATITIS 297 0.0056
532 URINE ODOUR ABNORMAL 33 0.0056
533 WRIST FRACTURE 67 0.0056
534 POOR QUALITY SLEEP 120 0.0056
535 DIARRHOEA 3584 0.0055
536 UNDERDOSE 404 0.0055
537 INFLUENZA 612 0.0055
538 GASTROINTESTINAL INFECTION 49 0.0055
539 MALNUTRITION 61 0.0054
540 CORONARY ARTERY DISEASE 165 0.0054
541 THROMBOSIS 438 0.0054
542 SMALL INTESTINAL OBSTRUCTION 67 0.0054
543 UROSEPSIS 50 0.0054
544 HIATUS HERNIA 70 0.0054
545 HYPERVENTILATION 31 0.0053
546 NEURALGIA 130 0.0053
547 BACK PAIN 1236 0.0053
548 PALPITATIONS 623 0.0053
549 HEART RATE IRREGULAR 120 0.0053
550 EMBOLISM 44 0.0053
551 MATERNAL EXPOSURE BEFORE PREGNANCY 36 0.0053
552 LYMPHOPENIA 74 0.0052
553 DRUG LEVEL DECREASED 53 0.0052
554 MENISCUS INJURY 32 0.0052
555 GLOMERULAR FILTRATION RATE DECREASED 63 0.0051
556 HERPES ZOSTER 294 0.0051
557 NOCTURIA 62 0.0051
558 TENDONITIS 79 0.0051
559 SKIN MASS 34 0.0051
560 DEPRESSED MOOD 267 0.0050
561 SENSORY DISTURBANCE 81 0.0050
562 DIARRHOEA HAEMORRHAGIC 47 0.0050
563 HYPERLIPIDAEMIA 60 0.0050
564 MIDDLE INSOMNIA 93 0.0050
565 ALANINE AMINOTRANSFERASE INCREASED 302 0.0049
566 BLOOD URINE PRESENT 93 0.0049
567 TENDERNESS 51 0.0049
568 ANAL INCONTINENCE 44 0.0049
569 INFLUENZA LIKE ILLNESS 402 0.0049
570 OFF LABEL USE 4268 0.0049
571 BLOOD PRESSURE ABNORMAL 96 0.0048
572 NAUSEA 3811 0.0048
573 MICTURITION URGENCY 55 0.0048
574 DIZZINESS 2394 0.0048
575 PULMONARY EMBOLISM 455 0.0048
576 ORAL DISORDER 35 0.0048
577 CARDIAC DISORDER 446 0.0048
578 BLOOD ALKALINE PHOSPHATASE INCREASED 118 0.0047
579 PELVIC FRACTURE 37 0.0047
580 HEPATOTOXICITY 105 0.0047
581 FALL 1559 0.0047
582 POST PROCEDURAL INFECTION 38 0.0047
583 CARDIOGENIC SHOCK 67 0.0047
584 ASPIRATION 51 0.0047
585 IMMUNOSUPPRESSION 41 0.0046
586 BLOOD IRON DECREASED 55 0.0046
587 DECREASED ACTIVITY 50 0.0046
588 COGNITIVE DISORDER 216 0.0046
589 SKIN EXFOLIATION 389 0.0046
590 RENAL IMPAIRMENT 387 0.0046
591 CONSTIPATION 1004 0.0046
592 DYSPHONIA 269 0.0046
593 VENTRICULAR FIBRILLATION 51 0.0046
594 NEUTROPHIL COUNT INCREASED 47 0.0046
595 RED BLOOD CELL COUNT DECREASED 131 0.0046
596 DEFAECATION URGENCY 32 0.0046
597 FURUNCLE 36 0.0045
598 COMA 215 0.0045
599 UTERINE LEIOMYOMA 33 0.0045
600 PAROSMIA 34 0.0045
601 BONE DENSITY DECREASED 141 0.0045
602 FLANK PAIN 42 0.0045
603 TREATMENT NONCOMPLIANCE 245 0.0045
604 OSTEOMYELITIS 81 0.0045
605 PSYCHIATRIC SYMPTOM 33 0.0045
606 ATAXIA 53 0.0045
607 ASPARTATE AMINOTRANSFERASE INCREASED 237 0.0045
608 LIMB INJURY 121 0.0045
609 LYMPHADENOPATHY 157 0.0044
610 ANHEDONIA 116 0.0044
611 TOOTH INFECTION 58 0.0044
612 RENAL TUBULAR NECROSIS 43 0.0044
613 DYSPHAGIA 415 0.0044
614 DRY EYE 218 0.0044
615 EYE INFECTION 49 0.0043
616 LACRIMATION INCREASED 131 0.0043
617 ORAL DISCOMFORT 60 0.0043
618 HYPOMAGNESAEMIA 60 0.0043
619 PURPURA 38 0.0043
620 MASS 60 0.0043
621 DERMATITIS ALLERGIC 54 0.0043
622 INFLAMMATORY BOWEL DISEASE 42 0.0043
623 RESTLESS LEGS SYNDROME 78 0.0043
624 DYSSTASIA 125 0.0043
625 RIB FRACTURE 88 0.0043
626 SEASONAL ALLERGY 60 0.0042
627 PHOTOSENSITIVITY REACTION 70 0.0042
628 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 221 0.0042
629 OXYGEN SATURATION DECREASED 238 0.0042
630 BIPOLAR DISORDER 46 0.0042
631 OROPHARYNGEAL DISCOMFORT 38 0.0042
632 MUSCULOSKELETAL CHEST PAIN 65 0.0042
633 OPTIC NEURITIS 38 0.0042
634 FISTULA 47 0.0042
635 HOSPITALISATION 639 0.0042
636 CONJUNCTIVITIS 77 0.0041
637 MOVEMENT DISORDER 133 0.0041
638 EYE DISORDER 136 0.0041
639 INTERSTITIAL LUNG DISEASE 200 0.0041
640 ADRENAL INSUFFICIENCY 50 0.0041
641 BODY HEIGHT DECREASED 44 0.0041
642 VISUAL IMPAIRMENT 505 0.0041
643 NEPHROLITHIASIS 186 0.0041
644 CELLULITIS 204 0.0040
645 CARDIAC MURMUR 35 0.0040
646 IMMUNE SYSTEM DISORDER 53 0.0040
647 HEART RATE INCREASED 397 0.0040
648 HAEMORRHOIDS 78 0.0040
649 MUSCLE TWITCHING 92 0.0040
650 BACTERIAL INFECTION 74 0.0040
651 ECONOMIC PROBLEM 60 0.0040
652 TRANSAMINASES INCREASED 88 0.0040
653 GOUT 71 0.0040
654 ELECTROCARDIOGRAM ABNORMAL 31 0.0039
655 DISEASE RECURRENCE 186 0.0039
656 DEAFNESS 102 0.0039
657 RENAL PAIN 41 0.0039
658 EMPHYSEMA 39 0.0039
659 LIGAMENT SPRAIN 38 0.0038
660 FOETAL EXPOSURE DURING PREGNANCY 312 0.0038
661 OROPHARYNGEAL PAIN 355 0.0038
662 MUSCULOSKELETAL DISCOMFORT 66 0.0038
663 INCREASED TENDENCY TO BRUISE 35 0.0038
664 VIRAL INFECTION 126 0.0038
665 MULTIPLE FRACTURES 62 0.0038
666 ANAEMIA 716 0.0038
667 TUBULOINTERSTITIAL NEPHRITIS 70 0.0037
668 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 671 0.0037
669 DYSURIA 137 0.0037
670 BRONCHOSPASM 53 0.0037
671 THROAT IRRITATION 166 0.0037
672 JOINT INJURY 79 0.0037
673 UVEITIS 50 0.0037
674 SKIN LACERATION 40 0.0037
675 URINARY TRACT INFECTION 626 0.0037
676 IMPAIRED GASTRIC EMPTYING 50 0.0037
677 HYPERTHYROIDISM 53 0.0037
678 BREAST PAIN 39 0.0037
679 OVARIAN CYST 36 0.0036
680 PAIN IN JAW 102 0.0036
681 FACIAL PAIN 32 0.0036
682 SPINAL PAIN 42 0.0036
683 DRUG INEFFECTIVE 4722 0.0036
684 WHITE BLOOD CELL COUNT DECREASED 387 0.0036
685 SKIN DISORDER 119 0.0036
686 COVID-19 PNEUMONIA 42 0.0036
687 BACTERAEMIA 42 0.0035
688 NEUROPATHY PERIPHERAL 336 0.0035
689 PNEUMONITIS 96 0.0035
690 BONE DISORDER 64 0.0035
691 FUNGAL INFECTION 117 0.0035
692 LUNG INFILTRATION 31 0.0035
693 PRODUCT QUALITY ISSUE 476 0.0035
694 ATRIAL FIBRILLATION 341 0.0035
695 INTERNAL HAEMORRHAGE 40 0.0035
696 ORAL PAIN 78 0.0035
697 PROTEINURIA 66 0.0035
698 PULMONARY HYPERTENSION 72 0.0035
699 PREMATURE DELIVERY 55 0.0035
700 RENAL FAILURE 458 0.0034
701 CRYING 125 0.0034
702 RENAL INJURY 102 0.0034
703 POLLAKIURIA 143 0.0034
704 SICKLE CELL ANAEMIA WITH CRISIS 54 0.0034
705 GASTROENTERITIS 50 0.0034
706 SCAB 39 0.0034
707 BALANCE DISORDER 295 0.0034
708 INCONTINENCE 36 0.0034
709 MUSCLE TIGHTNESS 55 0.0034
710 SPINAL DISORDER 32 0.0034
711 TOOTHACHE 61 0.0034
712 SPINAL FRACTURE 67 0.0033
713 GAMMA-GLUTAMYLTRANSFERASE INCREASED 74 0.0033
714 SKIN DISCOLOURATION 153 0.0033
715 SKIN INFECTION 37 0.0033
716 GASTROENTERITIS VIRAL 59 0.0033
717 HEPATOMEGALY 32 0.0033
718 DRY THROAT 33 0.0032
719 CHILLS 379 0.0032
720 TACHYCARDIA 287 0.0032
721 ACUTE KIDNEY INJURY 494 0.0032
722 TOXIC EPIDERMAL NECROLYSIS 49 0.0032
723 COVID-19 566 0.0032
724 HIP FRACTURE 103 0.0032
725 FEMUR FRACTURE 99 0.0032
726 PHOTOPHOBIA 60 0.0032
727 FLUSHING 324 0.0032
728 HYPOKALAEMIA 147 0.0032
729 LEUKOPENIA 159 0.0032
730 ORAL HERPES 62 0.0032
731 HAEMOGLOBIN DECREASED 326 0.0032
732 ACUTE RESPIRATORY FAILURE 61 0.0032
733 HEAD DISCOMFORT 56 0.0032
734 HYPOTENSION 634 0.0032
735 PERIPHERAL COLDNESS 43 0.0031
736 BLOOD POTASSIUM DECREASED 94 0.0031
737 HAEMATURIA 107 0.0031
738 KIDNEY INFECTION 61 0.0031
739 INFUSION SITE PAIN 40 0.0031
740 MENTAL STATUS CHANGES 86 0.0031
741 MYALGIA 526 0.0031
742 FLUID OVERLOAD 45 0.0031
743 BONE PAIN 181 0.0031
744 CHOLELITHIASIS 101 0.0031
745 SOMNOLENCE 615 0.0031
746 DERMATITIS 64 0.0031
747 BLOOD UREA INCREASED 51 0.0030
748 URINARY INCONTINENCE 90 0.0030
749 MENTAL DISORDER 132 0.0030
750 OESOPHAGITIS 33 0.0030
751 CLOSTRIDIUM DIFFICILE COLITIS 32 0.0030
752 ENCEPHALOPATHY 74 0.0030
753 BLOOD PRESSURE DECREASED 200 0.0030
754 MITRAL VALVE INCOMPETENCE 34 0.0030
755 SPINAL OPERATION 37 0.0030
756 GASTRITIS 79 0.0030
757 INCORRECT PRODUCT ADMINISTRATION DURATION 65 0.0030
758 MUSCULOSKELETAL DISORDER 57 0.0030
759 TOOTH FRACTURE 33 0.0030
760 FEELING JITTERY 57 0.0030
761 HYPERHIDROSIS 385 0.0030
762 QUALITY OF LIFE DECREASED 40 0.0030
763 SEDATION 78 0.0030
764 STAPHYLOCOCCAL INFECTION 98 0.0030
765 CHROMATURIA 67 0.0030
766 MYOCARDITIS 34 0.0030
767 DRUG RESISTANCE 76 0.0030
768 ERYTHEMA 608 0.0030
769 MULTIPLE SCLEROSIS 141 0.0029
770 ABSCESS 47 0.0029
771 BLOOD SODIUM DECREASED 55 0.0029
772 HOT FLUSH 219 0.0029
773 MOUTH ULCERATION 61 0.0029
774 INTESTINAL OBSTRUCTION 109 0.0029
775 DIALYSIS 41 0.0029
776 TREMOR 478 0.0029
777 PLEURAL EFFUSION 175 0.0029
778 DIABETES MELLITUS 219 0.0029
779 CHOKING 56 0.0029
780 PLATELET COUNT DECREASED 303 0.0028
781 CENTRAL NERVOUS SYSTEM LESION 39 0.0028
782 FEELING COLD 79 0.0028
783 FEBRILE NEUTROPENIA 187 0.0028
784 PULMONARY CONGESTION 37 0.0028
785 DEEP VEIN THROMBOSIS 181 0.0028
786 THERAPEUTIC RESPONSE SHORTENED 92 0.0028
787 VERTIGO 169 0.0028
788 FAECES DISCOLOURED 60 0.0028
789 SEPSIS 307 0.0027
790 BRAIN FOG 43 0.0027
791 MULTIPLE SCLEROSIS RELAPSE 187 0.0027
792 APHONIA 38 0.0027
793 ASCITES 79 0.0027
794 SPEECH DISORDER 140 0.0027
795 ILLNESS 273 0.0026
796 EYE HAEMORRHAGE 35 0.0026
797 DRUG LEVEL INCREASED 43 0.0026
798 LEUKOCYTOSIS 47 0.0026
799 INJECTION SITE IRRITATION 33 0.0026
800 FLATULENCE 147 0.0026
801 GINGIVAL BLEEDING 35 0.0026
802 INTERVERTEBRAL DISC PROTRUSION 56 0.0026
803 CORONARY ARTERY OCCLUSION 35 0.0025
804 ANAPHYLACTIC REACTION 141 0.0025
805 PULMONARY OEDEMA 113 0.0025
806 MENTAL IMPAIRMENT 61 0.0025
807 PREMATURE BABY 75 0.0025
808 HYPERSOMNIA 71 0.0025
809 HYPONATRAEMIA 138 0.0024
810 EJECTION FRACTION DECREASED 38 0.0024
811 ERUCTATION 47 0.0024
812 DISTURBANCE IN ATTENTION 131 0.0024
813 TOOTH DISORDER 54 0.0024
814 PRESYNCOPE 59 0.0024
815 DIPLOPIA 63 0.0024
816 SARS-COV-2 TEST POSITIVE 32 0.0024
817 DEHYDRATION 323 0.0024
818 CEREBROVASCULAR ACCIDENT 409 0.0024
819 UPPER LIMB FRACTURE 48 0.0024
820 THIRST 43 0.0024
821 NEUTROPHIL COUNT DECREASED 98 0.0024
822 DRUG INTERACTION 381 0.0024
823 NERVOUSNESS 125 0.0024
824 INTERNATIONAL NORMALISED RATIO INCREASED 68 0.0024
825 BRADYCARDIA 126 0.0024
826 AGEUSIA 59 0.0024
827 LETHARGY 136 0.0024
828 UNRESPONSIVE TO STIMULI 61 0.0024
829 INCREASED APPETITE 45 0.0024
830 OSTEONECROSIS 77 0.0023
831 PERICARDIAL EFFUSION 54 0.0023
832 FULL BLOOD COUNT DECREASED 47 0.0023
833 THROAT TIGHTNESS 63 0.0023
834 HYPERGLYCAEMIA 84 0.0023
835 IMPAIRED QUALITY OF LIFE 33 0.0023
836 MALIGNANT NEOPLASM PROGRESSION 235 0.0023
837 MULTIPLE ORGAN DYSFUNCTION SYNDROME 65 0.0023
838 DRUG EFFECT LESS THAN EXPECTED 34 0.0023
839 HYPERKALAEMIA 80 0.0023
840 HYPOGLYCAEMIA 110 0.0023
841 HALLUCINATION, AUDITORY 36 0.0023
842 LYMPHOMA 35 0.0023
843 ABDOMINAL PAIN LOWER 57 0.0023
844 FEELING ABNORMAL 539 0.0022
845 INTENTIONAL DOSE OMISSION 64 0.0022
846 SYNCOPE 223 0.0022
847 FEEDING DISORDER 45 0.0022
848 URINARY RETENTION 74 0.0022
849 DEVICE RELATED INFECTION 34 0.0022
850 THROMBOCYTOPENIA 247 0.0022
851 DYSGEUSIA 163 0.0022
852 CANDIDA INFECTION 37 0.0022
853 PRURITUS GENERALISED 47 0.0022
854 RETCHING 46 0.0022
855 BLOOD BILIRUBIN INCREASED 58 0.0021
856 ECZEMA 112 0.0021
857 EYE PAIN 120 0.0021
858 RASH ERYTHEMATOUS 100 0.0021
859 POST PROCEDURAL COMPLICATION 40 0.0021
860 TOOTH LOSS 43 0.0021
861 TINNITUS 95 0.0021
862 HEAD INJURY 65 0.0021
863 HAEMATOMA 53 0.0020
864 ACUTE MYOCARDIAL INFARCTION 60 0.0020
865 LIVER FUNCTION TEST ABNORMAL 59 0.0020
866 INTENTIONAL PRODUCT MISUSE 177 0.0020
867 SWOLLEN TONGUE 63 0.0020
868 THERAPEUTIC RESPONSE UNEXPECTED 89 0.0020
869 DEPRESSED LEVEL OF CONSCIOUSNESS 78 0.0020
870 SWELLING FACE 127 0.0019
871 METABOLIC ACIDOSIS 62 0.0019
872 EPISTAXIS 144 0.0019
873 NEEDLE ISSUE 56 0.0019
874 RESPIRATORY DISTRESS 53 0.0019
875 RASH PAPULAR 43 0.0019
876 HYPOACUSIS 82 0.0019
877 NEOPLASM PROGRESSION 66 0.0019
878 PRODUCT DOSE OMISSION ISSUE 553 0.0019
879 THINKING ABNORMAL 35 0.0019
880 SCAR 32 0.0019
881 LIP SWELLING 62 0.0019
882 NEUTROPENIA 252 0.0019
883 FRACTURE 35 0.0018
884 GASTRIC ULCER 35 0.0018
885 HYPOPHAGIA 47 0.0018
886 RESTLESSNESS 67 0.0018
887 METASTASES TO LIVER 32 0.0018
888 EYE PRURITUS 61 0.0018
889 PLASMA CELL MYELOMA 70 0.0018
890 TRANSIENT ISCHAEMIC ATTACK 60 0.0018
891 BLOOD CREATINE PHOSPHOKINASE INCREASED 51 0.0018
892 PRODUCT DOSE OMISSION IN ERROR 50 0.0018
893 SKIN CANCER 38 0.0018
894 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 95 0.0017
895 DEMENTIA 48 0.0017
896 SURGERY 100 0.0017
897 CARDIAC FAILURE CONGESTIVE 136 0.0017
898 ACNE 127 0.0017
899 PANIC ATTACK 61 0.0017
900 GLYCOSYLATED HAEMOGLOBIN INCREASED 42 0.0017
901 GASTROINTESTINAL HAEMORRHAGE 139 0.0017
902 HAEMORRHAGE 173 0.0017
903 RHABDOMYOLYSIS 69 0.0017
904 PALLOR 45 0.0017
905 MOOD ALTERED 45 0.0016
906 SEPTIC SHOCK 71 0.0016
907 VISUAL ACUITY REDUCED 53 0.0016
908 PANCYTOPENIA 89 0.0016
909 LOSS OF CONSCIOUSNESS 204 0.0016
910 RENAL FAILURE ACUTE 67 0.0016
911 HAEMATEMESIS 40 0.0016
912 SEIZURE 180 0.0016
913 BREAST CANCER 143 0.0015
914 MUCOSAL INFLAMMATION 40 0.0015
915 OSTEONECROSIS OF JAW 37 0.0015
916 EMOTIONAL DISTRESS 180 0.0015
917 ABASIA 36 0.0015
918 GASTRIC DISORDER 50 0.0015
919 VISION BLURRED 200 0.0015
920 BLOOD GLUCOSE INCREASED 274 0.0015
921 EYE SWELLING 54 0.0015
922 RESPIRATORY FAILURE 104 0.0014
923 CARDIAC FAILURE 114 0.0014
924 ANGER 47 0.0014
925 OVERDOSE 299 0.0014
926 VAGINAL HAEMORRHAGE 60 0.0014
927 INCORRECT DOSE ADMINISTERED 315 0.0014
928 DISEASE PROGRESSION 163 0.0014
929 EMOTIONAL DISORDER 42 0.0014
930 MYELOSUPPRESSION 49 0.0014
931 NERVOUS SYSTEM DISORDER 42 0.0013
932 DISORIENTATION 53 0.0013
933 UNEVALUABLE EVENT 101 0.0013
934 ANGIOEDEMA 58 0.0013
935 SUICIDAL IDEATION 120 0.0013
936 ARRHYTHMIA 62 0.0013
937 ELECTROCARDIOGRAM QT PROLONGED 47 0.0013
938 PAIN OF SKIN 35 0.0013
939 DRY SKIN 173 0.0013
940 RESPIRATORY ARREST 35 0.0013
941 JAUNDICE 34 0.0013
942 ACCIDENTAL OVERDOSE 46 0.0013
943 MOOD SWINGS 40 0.0013
944 LACTIC ACIDOSIS 40 0.0012
945 INJECTION SITE PRURITUS 81 0.0012
946 DYSKINESIA 49 0.0012
947 HEPATIC FAILURE 36 0.0012
948 THERAPY INTERRUPTED 85 0.0012
949 DRUG EFFECT INCOMPLETE 43 0.0012
950 NEOPLASM MALIGNANT 79 0.0012
951 CARDIAC ARREST 95 0.0011
952 BLOOD GLUCOSE DECREASED 55 0.0011
953 HALLUCINATION 86 0.0011
954 PRODUCT DOSE OMISSION 73 0.0011
955 DEATH 956 0.0011
956 INJECTION SITE MASS 41 0.0011
957 PROSTATE CANCER 89 0.0011
958 OCULAR HYPERAEMIA 52 0.0011
959 MYOCARDIAL INFARCTION 190 0.0011
960 AGITATION 79 0.0011
961 INJECTION SITE RASH 33 0.0011
962 NO ADVERSE EVENT 188 0.0010
963 CONVULSION 59 0.0010
964 BLINDNESS 42 0.0010
965 IRRITABILITY 61 0.0010
966 EYE IRRITATION 57 0.0010
967 DRUG ABUSE 82 0.0010
968 INJECTION SITE BRUISING 78 0.0010
969 RASH MACULAR 34 0.0010
970 INJECTION SITE PAIN 295 0.0010
971 NIGHTMARE 33 0.0010
972 INJECTION SITE SWELLING 72 0.0009
973 INJECTION SITE ERYTHEMA 116 0.0009
974 TOXICITY TO VARIOUS AGENTS 153 0.0009
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 62 0.0009
976 SUICIDE ATTEMPT 52 0.0009
977 INJECTION SITE HAEMORRHAGE 67 0.0008
978 DRUG EFFECT DECREASED 45 0.0008
979 PRODUCT SUBSTITUTION ISSUE 46 0.0008
980 DRUG DOSE OMISSION 127 0.0008
981 THERAPY CESSATION 39 0.0008
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
983 DEVICE DISLOCATION 32 0.0007
984 SKIN BURNING SENSATION 51 0.0007
985 AGGRESSION 32 0.0006
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 129 0.0006
987 PRODUCT STORAGE ERROR 45 0.0005
988 DRUG WITHDRAWAL SYNDROME 43 0.0005
989 DEVICE ISSUE 41 0.0005
990 DRUG DEPENDENCE 60 0.0004
991 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003